spacer
home > pmps > winter 2017 > watching the east
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Watching the East

The pharmaceutical industry is one of the most competitive sectors in the EU. It is the fifth largest industrial area and accounts for a high percentage of the global pharma market. According to the European Federation of Pharmaceutical Industries and Associations, few other fields can match its contribution to generating a trade surplus, investment in R&D and the creation of skilled employment in Europe.

While a large proportion of pharmaceutical development and manufacturing takes place on the western continent, central and eastern European countries are emerging as an attractive alternative for companies wishing to outsource parts of the supply chain due to factors such as accomplished workforces and competitive pricing.

European Landscape

The pharma sector in Europe has grown exponentially over the past ten years. Businesses have had to overcome a number of challenges, like escalating costs and downward price pressure from governments coupled with the need for faster turnaround times to bring new drugs to market, as well as increased demand for products.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Anthony Sheehan joined Saneca Pharma as Chief Executive Officer in 2015. With over 25 years’ experience in the pharma industry, he has worked as Site Managing Director at Stada as well as in various senior roles within the sector. Anthony also has experience in the automotive and engineering fields. He has an MBA from the University of Limerick, Ireland.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Introducing the new Rapidox 7100

When dealing with volatile applications such as those within chemical and combustion processes, you need a high specification instrument you can trust; the Rapidox 7100 Multigas Analyser is that instrument
More info >>

White Papers

Maximize the ROI of Your Post-Approval Research

Bioclinica

Expenditures in post-approval (Phase IV) research are going up across the pharmaceutical, biotech and medical device industries. Given the resources you’ve committed to post-approval research, you may be wondering if you’re getting the greatest possible return on your investment. Discover how to harness the power of post-approval research to increase data collection, reduce resource burn, save money, and maximize your ROI!
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement